BeiGene
BeiGene is a global biopharmaceutical company founded in 2010, focused on discovering, developing, manufacturing, and commercializing innovative cancer therapies. The company aims to improve treatment outcomes and patient access to cancer medicines worldwide. With over 3,400 employees, BeiGene operates research and development facilities and commercial offices across China, the United States, and Europe. The company's product portfolio includes BRUKINSA, a selective Bruton's tyrosine kinase inhibitor for various B-cell malignancies, and TEVIMBRA, an anti-PD-1 monoclonal antibody for solid tumors. BeiGene also has a robust pipeline with 32 clinical or commercial stage assets, including late-stage candidates targeting a range of cancers. The company conducts clinical trials in over 35 countries, reflecting its commitment to international standards in drug development and its strong market presence in major pharmaceutical markets.
Work at BeiGene in HR or recruiting? Claim this page
Headcount trend
BeiGene went from 1,725 employees in Jul 2023 to 1,806 in Jun 2025. Last 6 months: 72 people joined, 120 left.
Org structure
Headcount by department
Hiring now
See all jobsSalaries at BeiGene
All salaries1 salary profiles in the US
H-1B sponsorship
The department split adds up all the years listed above. FY2025 alone: 8 filings.
Peer reviews
Worked with someone at BeiGene?
Anonymous peer reviews on OffTheRecord
Similar companies
BeiGene FAQ
How many employees does BeiGene have?
BeiGene has about 1,806 employees, down 0.6% over the last 3 months (as of Jun 2025).
Does BeiGene sponsor H1B visas?
Yes. BeiGene filed 8 H1B (LCA) applications in FY2025, according to the latest U.S. Department of Labor disclosures. Most of them were for Operations roles.
What is BeiGene's revenue per employee?
BeiGene makes about $2.31M in revenue per employee, based on $4.18B annual revenue and 1,806 employees.
How much does BeiGene pay?
6figr has 1 salary profile for BeiGene in the US, with pay broken down by role, level, gender and ethnicity on the BeiGene salaries page. See BeiGene salaries
Is BeiGene a public company?
Yes. BeiGene is publicly traded under the ticker BGNE on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles. Updated 27 Nov 2025.
